| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.99▼ | 1.99▼ | 1.99▼ | 1.96▼ | 1.89▲ |
| MA10 | 1.98▼ | 1.98▼ | 1.98▼ | 1.95▼ | 1.71▲ |
| MA20 | 1.98▼ | 1.94▲ | 1.91▲ | 1.86▲ | 1.76▲ |
| MA50 | 1.91▲ | 1.93▲ | 1.89▲ | 1.68▲ | 2.16▼ |
| MA100 | 1.90▲ | 1.78▲ | 1.73▲ | 1.77▲ | 2.17▼ |
| MA200 | 1.74▲ | 1.79▲ | 1.82▲ | 2.09▼ | 3.27▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.000▲ | 0.003▲ | 0.000▲ | 0.069▲ |
| RSI | 49.577▼ | 51.406▲ | 52.598▲ | 56.090▲ | 52.365▲ |
| STOCH | 44.061 | 53.530 | 63.962 | 53.534 | 72.110 |
| WILL %R | -87.548▼ | -33.962 | -33.962 | -31.034 | -26.806 |
| CCI | -113.119▼ | -47.980 | 7.572 | 18.881 | 107.927▲ |
|
Tuesday, May 27, 2025 04:43 AM
Adagene Inc., a biotechnology company focused on antibody-based therapies, has announced that its Chief Strategy Officer, Mickael Chane-Du, will be participating in one-on-one investor meetings ...
|
|
Tuesday, May 27, 2025 04:30 AM
About AdageneAdagene Inc. (Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed to transforming the discovery and development of novel antibody-based cancer ...
|
|
Thursday, May 22, 2025 02:14 PM
Adagene Inc. (Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 1.88 | 1.985 | 1.88 | 1.95 | 1,898 |
| 12/06/25 | 2.00 | 2.04 | 1.89 | 1.96 | 51,055 |
| 11/06/25 | 1.95 | 2.015 | 1.95 | 1.98 | 678,148 |
| 09/06/25 | 1.88 | 2.01 | 1.83 | 1.91 | 86,966 |
| 06/06/25 | 1.78 | 2.045 | 1.78 | 1.99 | 73,123 |
| 05/06/25 | 1.92 | 1.9594 | 1.73 | 1.76 | 126,005 |
| 04/06/25 | 1.97 | 2.10 | 1.90 | 1.90 | 160,312 |
| 03/06/25 | 2.11 | 2.11 | 1.90 | 2.07 | 68,858 |
| 02/06/25 | 1.85 | 2.13 | 1.85 | 2.085 | 44,948 |
| 30/05/25 | 1.90 | 2.02 | 1.90 | 1.94 | 31,187 |
|
|
||||
|
|
||||
|
|